Established in early 2015, Akcea Therapeutics is a wholly owned subsidiary of Ionis Pharmaceuticals, the leader in RNA therap ... eutics. Akcea commercializes two medicines, and with Ionis, is advancing a mature pipeline of novel medicines discovered by Ionis and based on Ionis’ proprietary antisense technology. Our priority is to bring transformative medicines to patients by understanding patient and physician needs, preparing the market, creating market access, and commercializing our products on a global basis. We are driven by the knowledge that patients depend on us. Akcea Therapeutics has been acquired by Ionis Pharmaceuticals. For the latest job postings, please visit the Ionis LinkedIn page here: https://www.linkedin.com/company/ionis-pharmaceuticals/jobs/ read more